EUVIMEDEUVIMED entdecken
Open Access

The Utilization of MS-MLPA as the First-Line Test for the Diagnosis of Prader–Willi Syndrome in Thai Patients

Chanita Prapasrat iD, Preyaporn Onsod, Veerawat Korkiatsakul iD, Budsaba Rerkamnuaychoke, Duangrurdee Wattanasirichaigoon, Takol Chareonsirisuthigul iD

Journal of Pediatric Genetics · 01.12.2023 · 12 (04) · 273-279

DOI: 10.1055/s-0041-1741008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Genetics, erschienen am 01.12.2023. Verfasst von Chanita Prapasrat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prader–Willi syndrome (PWS) is a genetic disorder caused by the expression disruption of genes on the paternally inherited allele of chromosome 15q11.2-q13. Apart from clinical diagnostic criteria, PWS is confirmed by genetic testing. Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) is one of the molecular techniques used to analyze this syndrome. This study aimed to evaluate the concordance of the test results of MS-MLPA with conventional techniques in the diagnosis of PWS in Thai patients. Forty leftover specimens from routine genetic testing (MS-PCR and FISH) were tested to obtain MS-MLPA results. By comparison, perfect concordance was shown between the result of MS-MLPA and those of conventional techniques. In conclusion, MS-MLPA is an accurate and cost-effective assay that can be used to confirm PWS diagnosis with explicit deletion of affected genes.

Schlagwörter

Stichwörter der Autor:innen

Imprinting disorderMS-MLPAPWS

Autor:innen und Institutionen

  • Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Department of Pediatrics, Division of Medical Genetics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Chanita Prapasrat, Veerawat Korkiatsakul, Takol Chareonsirisuthigul

Zitieren

APA

Prapasrat, C., Onsod, P., Korkiatsakul, V., Rerkamnuaychoke, B., Wattanasirichaigoon, D., & Chareonsirisuthigul, T. (2023). The Utilization of MS-MLPA as the First-Line Test for the Diagnosis of Prader–Willi Syndrome in Thai Patients. Journal of Pediatric Genetics, 12(04), 273-279. https://doi.org/10.1055/s-0041-1741008

Vancouver

Prapasrat C, Onsod P, Korkiatsakul V, Rerkamnuaychoke B, Wattanasirichaigoon D, Chareonsirisuthigul T. The Utilization of MS-MLPA as the First-Line Test for the Diagnosis of Prader–Willi Syndrome in Thai Patients. Journal of Pediatric Genetics. 2023;12(04):273-279. doi:10.1055/s-0041-1741008

BibTeX
@article{Prapasrat2023,
  author = {Prapasrat, Chanita and Onsod, Preyaporn and Korkiatsakul, Veerawat and Rerkamnuaychoke, Budsaba and Wattanasirichaigoon, Duangrurdee and Chareonsirisuthigul, Takol},
  title = {The Utilization of MS-MLPA as the First-Line Test for the Diagnosis of Prader–Willi Syndrome in Thai Patients},
  journal = {Journal of Pediatric Genetics},
  year = {2023},
  volume = {12},
  number = {04},
  pages = {273--279},
  doi = {10.1055/s-0041-1741008}
}
Kostenlos starten →